RALNYAlnylam Pharmaceuticals Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
Alnylam Pharmaceuticals, Inc. Utilizing its proprietary drug delivery technology platforms, Alnylam is dedicated to the R&D, manufacturing, and commercialization of breakthrough small interfering RNA (siRNA) medicines targeting rare diseases, cardiovascular conditions, metabolic disorders, and central nervous system diseases. As an industry pioneer, it possesses a strong core moat in the commercialization and pipeline expansion of gene-silencing technologies.
- Macro context: RALNY is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
—
14D
—
30D
—
1Y
—
All-time
-31.72%
Market Cap
$9.41K
24h Volume
$0
On-Chain Holders
1
Summed across all deployed chains (per-chain wallets not de-duplicated)
Key facts
via /coins/{id}Market Cap Rank
#11791
Circulating Supply
56.78
Total Supply
56.78
All-Time High
$257.8 · 2026-09-28
Categories
News & Insights
Also tokenized by
Alnylam Pharmaceuticals Tokenized Stock (Reality) is issued as 2 separate tokens across different issuers.
| Issuer | Token | Price | Market Cap | 24h Volume | Networks |
|---|---|---|---|---|---|
| xStocks | ALNALNYX | — | — | — | — |
Alerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RALNY crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RALNY — the second it drops.
Daily summary
A once-a-day digest of RALNY's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RALNY — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RALNY paired with the latest issuer, regulatory and market news.